Cubist Systematic Strategies, LLC - EPIZYME INC ownership

EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 82 filers reported holding EPIZYME INC in Q4 2014. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of EPIZYME INC
ValueSharesWeighting
Q2 2022$19,000
+137.5%
13,144
+82.6%
0.00%
Q1 2022$8,000
-98.3%
7,200
-96.2%
0.00%
-100.0%
Q4 2021$475,000
+365.7%
189,987
+858.0%
0.01%
+400.0%
Q3 2021$102,000
-66.6%
19,831
-46.0%
0.00%
-66.7%
Q2 2021$305,000
-18.2%
36,697
-14.3%
0.00%
-40.0%
Q1 2021$373,000
+116.9%
42,823
+169.9%
0.01%
+150.0%
Q4 2020$172,000
+75.5%
15,867
+93.4%
0.00%
+100.0%
Q3 2020$98,000
-51.2%
8,206
-34.6%
0.00%
-66.7%
Q2 2020$201,000
-63.7%
12,545
-64.8%
0.00%
-80.0%
Q1 2020$553,000
-33.9%
35,652
+4.8%
0.02%0.0%
Q4 2019$837,000
+104.1%
34,029
-14.5%
0.02%
+87.5%
Q3 2019$410,000
+75.2%
39,792
+113.3%
0.01%
+100.0%
Q2 2019$234,000
-8.9%
18,654
-10.2%
0.00%
-50.0%
Q1 2019$257,000
-48.0%
20,780
-74.1%
0.01%
-65.2%
Q4 2018$494,000
+379.6%
80,123
+724.6%
0.02%
+283.3%
Q3 2018$103,000
-68.4%
9,717
-59.6%
0.01%
-62.5%
Q2 2018$326,000
-28.0%
24,036
-5.9%
0.02%
-40.7%
Q1 2018$453,000
+160.3%
25,531
+84.5%
0.03%
+200.0%
Q4 2017$174,000
+596.0%
13,838
+1242.2%
0.01%
+800.0%
Q2 2015$25,000
-72.8%
1,031
-79.0%
0.00%
-80.0%
Q1 2015$92,000
+119.0%
4,906
+214.5%
0.01%
+66.7%
Q3 2014$42,0001,5600.00%
Other shareholders
EPIZYME INC shareholders Q4 2014
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 1,558,108$27,656,0009.20%
Palo Alto Investors LP 6,895,075$122,388,0005.23%
NEA Management Company, LLC 6,460,851$114,680,0005.10%
Foresite Capital Management III, LLC 998,278$17,719,0003.86%
ORACLE INVESTMENT MANAGEMENT INC 396,325$7,035,0001.70%
Redmile Group, LLC 2,011,989$35,713,0001.38%
Rock Springs Capital Management LP 1,275,000$22,631,0000.96%
Virtus ETF Advisers LLC 59,330$1,053,0000.91%
Sio Capital Management, LLC 72,826$1,293,0000.78%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 960,970$17,057,0000.59%
View complete list of EPIZYME INC shareholders